Trade Ultragenyx Pharmaceutical Inc - RARE CFD
What is Ultragenyx Pharmaceutical Inc (RARE)?
Ultragenyx Pharmaceutical Inc is a biopharmaceutical company dedicated to the development of novel therapies for rare and ultra-rare genetic diseases. The company focuses on identifying and commercializing treatments that address serious medical conditions with limited or no existing options. Its portfolio includes therapies targeting metabolic, skeletal, and neuromuscular disorders. Ultragenyx Pharmaceutical Inc employs a research-driven approach, utilizing genetic and molecular biology techniques to develop its product candidates. The company collaborates with academic institutions, patient advocacy groups, and regulatory bodies to facilitate drug development and approval processes. Its mission centers on improving the quality of life for patients affected by rare diseases through innovative pharmaceutical solutions.
Ultragenyx Pharmaceutical Inc Stock Price Today: Live Overview
The price today is shaped by active session trading, with Ultragenyx Pharmaceutical Inc at $21.48. Prices have ranged from $20.65 to $21.48, showing a daily fluctuation of +2.1063%.
FAQ: Ultragenyx Pharmaceutical Inc (RARE)
What is the current price of RARE stock?
The latest price stands at $21.48.
Does RARE pay dividends?
Ultragenyx Pharmaceutical Inc does not pay dividends.
Does RARE have a formal corporate presence or regional headquarters in the UAE?
Ultragenyx Pharmaceutical Inc has no direct office or subsidiary in the UAE and distributes products through regional partners.
What is RARE best known for?
The company is most famous for developing therapies for rare genetic diseases.
What assets are typically shown together with RARE?
Commonly shown alongside RARE: Gotham 1000 Value ETF, GRAIL Inc, China Minsheng Banking
Latest shares articles



